Thailand’s pharmaceutical industry continues to face multiple challenges, particularly its heavy reliance on imported active ...

Jyong Biotech Ltd. (the "Company"), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative ...

Organon faces profitability challenges and revenue declines. The valuation appears fair given the weak revenue outlook. See ...

President Donald Trump’s executive order, which threatens pharmaceutical companies with targeted retaliation and lawsuits if ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

On November 5, 2024, voters sent a clear message by electing Donald Trump. In the last five months, President Trump has delivered on the many promises he made t ...

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration (FDA) approved the company’s Mavyret treatment label expansion. The approval ...

President Trump just issued an executive order to rebalance the global pharmaceutical market -- by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.

Administration officials have good intentions. They’re trying to shake up the plainly unacceptable status quo, in which ...

The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs - Are you ...